Stock Analiz

Allogene Therapeutics, Inc. (ALLO) stock forecast and price target

Price $0.84 · data as of November 13, 2026

12-month price target

Average target$9.00
Upside / downside+973.1%
Analysts9
ConsensusStrong buy
Low $4.00Average $9.00High $14.00

Gold marker: average target · white marker: today’s price ($0.84)

Analyst ratings

Strong buy 3Buy 8Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.58+32.6%$4M
Next fiscal year
ends December 31, 2027
$-0.61−6.1%$12M
Next quarter
ends December 31, 2026
$-0.15+11.5%$2220
Quarter after
ends March 31, 2027
$-0.14+24.1%$3330

Consensus of the analysts covering Allogene Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Allogene Therapeutics stock price target?

The average 12-month target from 9 analysts is $9.00, 973.1% above the current price of $0.84 Targets range from $4.00 to $14.00.

Is Allogene Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 8 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Allogene Therapeutics expected to earn?

Analysts expect EPS of $-0.58 for the fiscal year ending December 31, 2026 and $-0.61 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.